InvestorsHub Logo

NRS

Followers 41
Posts 462
Boards Moderated 0
Alias Born 03/27/2014

NRS

Re: None

Thursday, 02/02/2023 9:08:10 AM

Thursday, February 02, 2023 9:08:10 AM

Post# of 185
A number of large investors have recently made changes to their positions in the business. Polar Capital Holdings Plc lifted its stake in shares of Summit Therapeutics by 2.5% during the 1st quarter. Polar Capital Holdings Plc now owns 6,272,509 shares of the company’s stock worth $15,368,000 after purchasing an additional 154,598 shares during the period. Millennium Management LLC purchased a new position in shares of Summit Therapeutics during the 2nd quarter worth $457,000. BlackRock Inc. lifted its stake in shares of Summit Therapeutics by 39.3% during the 3rd quarter. BlackRock Inc. now owns 421,086 shares of the company’s stock worth $500,000 after purchasing an additional 118,878 shares during the period. Marshall Wace LLP purchased a new position in shares of Summit Therapeutics during the 3rd quarter worth $167,000. Finally, Renaissance Technologies LLC purchased a new position in shares of Summit Therapeutics during the 2nd quarter worth $49,000. Hedge funds and other institutional investors own 1.59% of the company’s stock.
https://www.etfdailynews.com/2023/02/01/summit-therapeutics-nasdaqsmmt-cut-to-sell-at-stocknews-com/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SMMT News